Lilly’s Tirzepatide Shows Strong Weight Loss Efficacy in Phase III Study

Full results from the Phase III SURMOUNT-3 trial showed that Eli Lilly’s tirzepatide induces strong and long-lasting weight loss when given after an intensive lifestyle intervention program, the company announced Sunday.